Anti-MRGRD/ MRGPRD/ MRGD monoclonal antibody

Anti-MRGRD/ MRGPRD/ MRGD antibody for FACS & in-vivo assay

Target products collectionGo to MRGPRD/MRGPRD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0830-Ab-1/ GM-Tg-hg-MP0830-Ab-2Anti-Human MRGPRD monoclonal antibodyHuman
GM-Tg-rg-MP0830-Ab-1/ GM-Tg-rg-MP0830-Ab-2Anti-Rat MRGPRD monoclonal antibodyRat
GM-Tg-mg-MP0830-Ab-1/ GM-Tg-mg-MP0830-Ab-2Anti-Mouse MRGPRD monoclonal antibodyMouse
GM-Tg-cynog-MP0830-Ab-1/ GM-Tg-cynog-MP0830-Ab-2Anti-Cynomolgus/ Rhesus macaque MRGPRD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0830-Ab-1/ GM-Tg-felg-MP0830-Ab-2Anti-Feline MRGPRD monoclonal antibodyFeline
GM-Tg-cang-MP0830-Ab-1/ GM-Tg-cang-MP0830-Ab-2Anti-Canine MRGPRD monoclonal antibodyCanine
GM-Tg-bovg-MP0830-Ab-1/ GM-Tg-bovg-MP0830-Ab-2Anti-Bovine MRGPRD monoclonal antibodyBovine
GM-Tg-equg-MP0830-Ab-1/ GM-Tg-equg-MP0830-Ab-2Anti-Equine MRGPRD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0830-Ab-1/ GM-Tg-hg-MP0830-Ab-2; GM-Tg-rg-MP0830-Ab-1/ GM-Tg-rg-MP0830-Ab-2;
GM-Tg-mg-MP0830-Ab-1/ GM-Tg-mg-MP0830-Ab-2; GM-Tg-cynog-MP0830-Ab-1/ GM-Tg-cynog-MP0830-Ab-2;
GM-Tg-felg-MP0830-Ab-1/ GM-Tg-felg-MP0830-Ab-2; GM-Tg-cang-MP0830-Ab-1/ GM-Tg-cang-MP0830-Ab-2;
GM-Tg-bovg-MP0830-Ab-1/ GM-Tg-bovg-MP0830-Ab-2; GM-Tg-equg-MP0830-Ab-1/ GM-Tg-equg-MP0830-Ab-2
Products NameAnti-MRGPRD monoclonal antibody
Formatmab
Target NameMRGPRD
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MRGPRD benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species MRGRD/ MRGPRD/ MRGD VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP003538human MRGPRD Lentivirus particle
    ORF Viral VectorpGMLP003538human MRGPRD Lentivirus plasmid
    ORF Viral VectorpGMAAV000105mouse Mrgprd AAV plasmid
    ORF Viral VectorvGMAAV000105mouse Mrgprd AAV particle


    Target information

    Target IDGM-MP0830
    Target NameMRGPRD
    Gene ID116512,211578,293648,709555,100060147
    Gene Symbol and SynonymsGm499,Mgrd,MRGD,MRGPRD,TGR7
    Uniprot AccessionQ8TDS7,Q7TN41
    Uniprot Entry NameMRGRD_HUMAN,MRGRD_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172938
    Target ClassificationGPCR

    The target: MRGPRD, gene name: MRGPRD, also named as MRGD, TGR7. Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.